The invisible loss
Judgment, caveats, alternatives, pitfalls, and recovery logic often remain spoken or tacit and are hard to reuse later.
SURGICAL KNOWLEDGE INFRASTRUCTURE · YOKOHAMA, JAPAN
Scheduled exhibitor · JHVS 2026 · Oct 7–9 · PACIFICO Yokohama · Booth V-83
Make surgical expertise compound.
MY ROBOTS is building a physician-reviewed workspace that turns permitted surgical records into reusable knowledge for preparation, reflection and education. The goal is not more video. It is to preserve the learning that would otherwise disappear with the case.
Physician reviewedHospital governedEducation & knowledge transfer
For education and knowledge transfer. Not autonomous diagnosis or treatment decisions.
CURRENT PRIVATE EVALUATION UI · NON-CLINICAL EXAMPLE
Representative MY ROBOTS Today workspace used in the current private evaluation.
Source-linked
Clinician reviewed
MY ROBOTS / Surgical Knowledge InfrastructurePrivate evaluation in progress · pilot and partner discussions underway
2026 MOMENTUM
Signals that help investors and partners understand the current stage.
External programs and exhibitions are credibility signals, not customer validation.
NVIDIA InceptionParticipation approved · Sep 2026
JETRO GSAP 2026 — StartX AISelected · StartX AI cohort of 20
J-StarX US Healthcare Breakthrough — FoundationalSelected · Foundational cohort of 10
Qualcomm AI Program for Innovators 2026 — APACShortlisted — 15 startups / Mentorship Phase
HVC KYOTO 2026Selected · MedTech
01 / WHY NOW
Hospitals already record the case. The learning can still disappear.
Video preserves what happened. It rarely preserves why an experienced clinician noticed something, changed course, or warned the next learner. MY ROBOTS is designed to structure that missing layer with clinician review and hospital governance.
Why now
Permitted video, audio, and modern AI can draft useful candidates. A reviewed workflow is needed so those candidates become trusted knowledge rather than raw output.
Category
MY ROBOTS is not “just more recording.” It is surgical knowledge infrastructure for preparation, reflection, education, and institutional memory.
02 / PRODUCT EXPERIENCE
A private evaluation UI that already shows the workflow clearly.
The current interface is designed around a simple operating model: capture source material, review evidence, approve reusable knowledge, and return to the exact source moment later.
Multilingual UI supportThe product direction is being presented with multilingual UI pathways for English, Japanese, Chinese, Korean, Spanish, and Hindi.
03 / GROWTH MODEL
Start focused. Expand by procedure, site, and learning use case.
01
1. Focused entry point
Start with one procedure and one hospital workflow.
02
2. Reviewed knowledge loop
Turn captured evidence into approved, searchable knowledge.
03
3. Institutional reuse
Support preparation, review conferences, and education.
04
4. Expansion
Add procedures, departments, and partner integrations after workflow fit is proven.
04 / CURRENT STAGE
Build evidence before claiming scale.
Current product
Private evaluation UI and workflow structure are already visible in the product screens above.
Validation posture
Clinical validation targets are framed as targets, not achieved results. The company is intentionally avoiding unsupported outcome claims.
Commercial direction
The next proof points are structured hospital evaluation, workflow fit, willingness to pay, and repeatable deployment.
Governance posture
Hospital governance, clinician review, provenance, role-based access, and auditability are central to the product direction.
05 / RECOGNITION & PROGRAMS
External signals across AI, healthcare, and global expansion.
Selection and participation records, with links to the relevant announcements. NVIDIA participation is a company announcement; its external link explains the program.
NVIDIA Inception
Participation approved · Sep 2026
NVIDIA Inception program information ↗JETRO GSAP 2026 — StartX AI
Selected · StartX AI cohort of 20
Official announcement ↗J-StarX US Healthcare Breakthrough — Foundational
Selected · Foundational cohort of 10
Official announcement ↗Qualcomm AI Program for Innovators 2026 — APAC
Shortlisted — 15 startups / Mentorship Phase
Official announcement ↗HVC KYOTO 2026
Selected · MedTech
Official announcement ↗AstraZeneca i2.JP
Network participation · Aug 2026
Official announcement ↗Japan Healthcare Venture Summit 2026
Scheduled exhibitor · Booth V-83
Official exhibitor list ↗Program participation does not establish customer adoption, clinical efficacy, regulatory approval, investment or product endorsement.
View all programs and sources →Updated: October 5, 2026
06 / FOUNDER & COMPANY
Built from decades inside medtech and the operating room.
Yoichi MiyazakiFounder
Across nearly three decades in medical devices and operating-room environments, the same issue repeated: valuable judgment is often explained in the moment but rarely becomes reusable organizational knowledge.
MY ROBOTS was founded to turn that gap into an institutional learning system while keeping clinicians responsible for what becomes trusted knowledge.
“The scarce asset is not another recording. It is the reasoning that gives the recording meaning.”
CompanyMY ROBOTS Inc.
Founded2023
Based inYokohama, Japan
FocusSurgical Knowledge Infrastructure
NEWS / OCT 09, 2026
MY ROBOTS Advances to the Kanto Regional Round of NIKKEI THE PITCH GROWTH 2026–27
MY ROBOTS has advanced through the selection process to the Kanto regional round, scheduled for November 13, 2026 at Station Conference Tokyo.
Read the full announcement →Investment · hospital evaluation · collaboration · programs
Contact
If you would like to discuss investment, hospital evaluation, collaboration, research, or program-related topics, please feel free to contact us. A short introduction to your organization and interests is enough to start.
Please notePlease do not submit patient information, case images, medical records, or other sensitive clinical data through this form.